
Neeraj Sharma
Examiner (ID: 5222, Phone: (571)270-5487 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2626 |
| Total Applications | 582 |
| Issued Applications | 475 |
| Pending Applications | 51 |
| Abandoned Applications | 71 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9735902
[patent_doc_number] => 20140271614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'DIRECTED SEQUENCE POLYMER COMPOSITIONS AND ANTIBODIES THEREOF FOR THE TREATMENT OF PROTEIN CONFORMATIONAL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/025223
[patent_app_country] => US
[patent_app_date] => 2013-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 24926
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14025223
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/025223 | DIRECTED SEQUENCE POLYMER COMPOSITIONS AND ANTIBODIES THEREOF FOR THE TREATMENT OF PROTEIN CONFORMATIONAL DISORDERS | Sep 11, 2013 | Abandoned |
Array
(
[id] => 10353577
[patent_doc_number] => 20150238582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'INDIVIDUALIZED IMMUNOMODULATION THERAPY FOR NEURODEGENERATIVE DISORDERS, CNS INJURY AND AGE-RELATED DEMENTIA'
[patent_app_type] => utility
[patent_app_number] => 14/427089
[patent_app_country] => US
[patent_app_date] => 2013-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 32958
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427089
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/427089 | INDIVIDUALIZED IMMUNOMODULATION THERAPY FOR NEURODEGENERATIVE DISORDERS, CNS INJURY AND AGE-RELATED DEMENTIA | Sep 9, 2013 | Abandoned |
Array
(
[id] => 9191024
[patent_doc_number] => 20130330339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'LEVELS OF BLYS/APRIL HETEROTRIMERS IN SERUM AND USE IN DIAGNOSTIC METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/972186
[patent_app_country] => US
[patent_app_date] => 2013-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18124
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13972186
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/972186 | Levels of BLyS/APRIL heterotrimers in serum and use in diagnostic methods | Aug 20, 2013 | Issued |
Array
(
[id] => 9370304
[patent_doc_number] => 20140080177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'ANTICALINS'
[patent_app_type] => utility
[patent_app_number] => 13/970928
[patent_app_country] => US
[patent_app_date] => 2013-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15945
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13970928
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/970928 | ANTICALINS | Aug 19, 2013 | Abandoned |
Array
(
[id] => 11429087
[patent_doc_number] => 09567395
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-14
[patent_title] => 'Methods of treating a tauopathy'
[patent_app_type] => utility
[patent_app_number] => 14/421073
[patent_app_country] => US
[patent_app_date] => 2013-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 75
[patent_no_of_words] => 49602
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14421073
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/421073 | Methods of treating a tauopathy | Aug 14, 2013 | Issued |
Array
(
[id] => 9198755
[patent_doc_number] => 20130338070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'FGF-9 VARIANTS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/954347
[patent_app_country] => US
[patent_app_date] => 2013-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 26248
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13954347
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/954347 | FGF-9 variants and methods of use thereof | Jul 29, 2013 | Issued |
Array
(
[id] => 9162039
[patent_doc_number] => 20130310316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'METHOD AND PRODUCT FOR TREATMENT AND/OR PREVENTION OF COMPLICATIONS OF PREMATURITY'
[patent_app_type] => utility
[patent_app_number] => 13/949750
[patent_app_country] => US
[patent_app_date] => 2013-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11116
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13949750
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/949750 | METHOD AND PRODUCT FOR TREATMENT AND/OR PREVENTION OF COMPLICATIONS OF PREMATURITY | Jul 23, 2013 | Abandoned |
Array
(
[id] => 11560484
[patent_doc_number] => 09623044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-18
[patent_title] => 'Chitosan hydrogel for repairing nerve tissue'
[patent_app_type] => utility
[patent_app_number] => 14/414994
[patent_app_country] => US
[patent_app_date] => 2013-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 7554
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14414994
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/414994 | Chitosan hydrogel for repairing nerve tissue | Jul 15, 2013 | Issued |
Array
(
[id] => 11304792
[patent_doc_number] => 09512178
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Neurogenic brain-derived neurotrophic factor peptides'
[patent_app_type] => utility
[patent_app_number] => 13/939352
[patent_app_country] => US
[patent_app_date] => 2013-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 27
[patent_no_of_words] => 9525
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13939352
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/939352 | Neurogenic brain-derived neurotrophic factor peptides | Jul 10, 2013 | Issued |
Array
(
[id] => 10317253
[patent_doc_number] => 20150202257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-23
[patent_title] => 'METHODS AND COMPOSITIONS FOR METABOLIC REGULATION'
[patent_app_type] => utility
[patent_app_number] => 14/413927
[patent_app_country] => US
[patent_app_date] => 2013-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26771
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14413927
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/413927 | Methylation-controlled J protein (MCJ) for treatment of liver disease and altering mitochondrial metabolism | Jul 9, 2013 | Issued |
Array
(
[id] => 9943293
[patent_doc_number] => 08992589
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-31
[patent_title] => 'Using light to regulate uterine contractions'
[patent_app_type] => utility
[patent_app_number] => 13/938485
[patent_app_country] => US
[patent_app_date] => 2013-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2982
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13938485
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/938485 | Using light to regulate uterine contractions | Jul 9, 2013 | Issued |
Array
(
[id] => 10307592
[patent_doc_number] => 20150192594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'FIBROBLAST GROWTH FACTOR RECEPTORS AS DIAGNOSTIC MARKERS OF ACQUIRED SENSORY NEURONOPATHIES'
[patent_app_type] => utility
[patent_app_number] => 14/417918
[patent_app_country] => US
[patent_app_date] => 2013-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9686
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417918
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/417918 | Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies | Jun 27, 2013 | Issued |
Array
(
[id] => 10990402
[patent_doc_number] => 20160187347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'BIOMARKER TEST FOR PREDICTION OR EARLY DETECTION OF PREECLAMPSIA AND/OR HELLP SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 14/407516
[patent_app_country] => US
[patent_app_date] => 2013-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 13021
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14407516
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/407516 | Biomarker test for prediction or early detection of preeclampsia and/or HELLP syndrome | Jun 12, 2013 | Issued |
Array
(
[id] => 9384575
[patent_doc_number] => 20140088057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'METHODS OF TREATING PRE-TERM LABOR'
[patent_app_type] => utility
[patent_app_number] => 13/896507
[patent_app_country] => US
[patent_app_date] => 2013-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6622
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13896507
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/896507 | METHODS OF TREATING PRE-TERM LABOR | May 16, 2013 | Abandoned |
Array
(
[id] => 10262349
[patent_doc_number] => 20150147346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'REPLIKIN SEQUENCES AND THEIR ANTIBODIES FOR DIAGNOSTICS, THERAPEUTICS, AND VACCINES AGAINST PRION AND NEURODEGENERATIVE DISORDERS INCLUDING ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/398376
[patent_app_country] => US
[patent_app_date] => 2013-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16554
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398376
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/398376 | REPLIKIN SEQUENCES AND THEIR ANTIBODIES FOR DIAGNOSTICS, THERAPEUTICS, AND VACCINES AGAINST PRION AND NEURODEGENERATIVE DISORDERS INCLUDING ALZHEIMER'S DISEASE | Apr 30, 2013 | Abandoned |
Array
(
[id] => 11845710
[patent_doc_number] => 09733261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-15
[patent_title] => 'Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury'
[patent_app_type] => utility
[patent_app_number] => 14/396377
[patent_app_country] => US
[patent_app_date] => 2013-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19378
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14396377
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/396377 | Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury | Apr 23, 2013 | Issued |
Array
(
[id] => 9971156
[patent_doc_number] => 09018165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-28
[patent_title] => 'Process for the synchronization of ovulation for timed breeding without heat detection'
[patent_app_type] => utility
[patent_app_number] => 13/868487
[patent_app_country] => US
[patent_app_date] => 2013-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 4279
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13868487
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/868487 | Process for the synchronization of ovulation for timed breeding without heat detection | Apr 22, 2013 | Issued |
Array
(
[id] => 9120843
[patent_doc_number] => 20130287765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'FSH AND FSH RECEPTOR MODULATOR COMPOSITIONS AND METHODS FOR INHIBITING OSTEOCLASTIC BONE RESORPTION AND BONE LOSS IN OSTEOPOROSIS'
[patent_app_type] => utility
[patent_app_number] => 13/862105
[patent_app_country] => US
[patent_app_date] => 2013-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16775
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13862105
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/862105 | FSH AND FSH RECEPTOR MODULATOR COMPOSITIONS AND METHODS FOR INHIBITING OSTEOCLASTIC BONE RESORPTION AND BONE LOSS IN OSTEOPOROSIS | Apr 11, 2013 | Abandoned |
Array
(
[id] => 9865591
[patent_doc_number] => 20150045610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-12
[patent_title] => 'METHOD OF MODIFYING SPERMATOGENESIS, SPERMIOGENESIS AND/OR FERTILITY IN MAMMALS'
[patent_app_type] => utility
[patent_app_number] => 14/391324
[patent_app_country] => US
[patent_app_date] => 2013-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 22242
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14391324
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/391324 | METHOD OF MODIFYING SPERMATOGENESIS, SPERMIOGENESIS AND/OR FERTILITY IN MAMMALS | Apr 9, 2013 | Abandoned |
Array
(
[id] => 9943927
[patent_doc_number] => 08993227
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-31
[patent_title] => 'Cancer prognosis by determining phosphorylation of a Xom polypeptide'
[patent_app_type] => utility
[patent_app_number] => 13/859285
[patent_app_country] => US
[patent_app_date] => 2013-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18866
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13859285
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/859285 | Cancer prognosis by determining phosphorylation of a Xom polypeptide | Apr 8, 2013 | Issued |